Japanese scientists trigger biosecurity concerns with engineered BIRD FLU virus made from two different strains

  • Japanese scientists engineered a novel bird flu strain (Vac-3) by merging genetic material from H5N3 and H6N1 viruses, raising concerns about lab-made pandemics.
  • The study avoided the term “gain-of-function,” but the research fits its definition – enhancing a pathogen’s immunogenicity and potentially increasing its danger if leaked.
  • Researchers tested the synthetic virus on primates using a whole-particle vaccine (WPV), preserving the virus’s full structure, which could carry unforeseen risks.
  • Similar experiments – including U.S.-funded H5N1 strains with 100 percent mammal lethality – highlight a trend of controversial, high-risk virology with minimal oversight.
  • Critics warn that creating and manipulating deadly pathogens in labs – ostensibly for vaccine development – could lead to accidental releases or misuse, echoing past lab-related disasters like Wuhan coronavirus (COVID-19).

In a move that has reignited fears of lab-engineered pandemics, Japanese scientists have created a never-before-seen strain of bird flu by merging two wild viruses.

They detailed their experiment in a study published July 23 in NPJ Vaccines. The study authors detailed how they assembled a synthetic pathogen dubbed Vac-3 from genetic material taken from H5N3 and H6N1 influenza strains found in ducks.

The virus, which was grown in eggs and chemically inactivated, was then tested on primates as part of a vaccine experiment. Researchers later exposed the vaccinated macaques to a lethal H5N1 strain originally isolated from a human fatality.

Such experiments, conducted in biosafety level 3 (BSL-3) labs, carry inherent risks – especially if a lab leak occurs. But with U.S. labs already embroiled in controversy over similar gain-of-function research (GOFR), critics warn that such experiments risk unleashing another man-made disaster.

The newly engineered strain does not occur naturally, creating a chimeric pathogen with unknown immunological properties. Unlike traditional flu vaccines that use weakened or fragmented viruses, Japan’s whole-particle vaccine kept the virus intact – including its RNA – to provoke a stronger immune reaction. (Related: Breaking: Japanese scientists engineer hybrid BIRD FLU virus for predatory VACCINE production.)

This approach, while potentially more effective, raises red flags. By preserving the virus’s full structure, researchers essentially tricked the immune system into mounting an exaggerated defense—a process that could carry unforeseen risks.

Gain-of-function research by another name?

Though the study avoids using GOFR, the research fits the definition. The White House’s 2025 Executive Order defines it as any work that enhances a pathogen’s ability to cause disease or disrupt immune responses. By merging two viruses to create a novel strain with heightened immunogenicity, Japanese scientists have effectively altered how the virus interacts with host immunity—a hallmark of GOFR.

Worse, this is not an isolated case. The study follows revelations that U.S. researchers – funded by a $59 million federal contract – engineered a lab-made H5N1 strain that killed 100 percent of exposed mammals. Meanwhile, Washington and Tokyo are collaborating on other projects, including hybrid horse-human flu viruses that replicate at alarming speeds.

Given that the origins of Wuhan coronavirus (COVID-19) remain hotly debated – with U.S. intelligence agencies acknowledging a likely lab-related incident – these experiments beg the question. Are we courting disaster in the name of scientific progress?

This is not the first time vaccine development has blurred the line between public health and biosecurity threats. The same U.S. labs involved in the H5N1 experiments have also worked on drug-resistant strains and used aborted fetal cells engineered with SV40, a cancer-linked virus, to accelerate flu replication.

Such experiments are being justified as preparation for future pandemics. But critics argue that creating deadlier viruses in the lab only increases the likelihood of accidental release – or worse, deliberate misuse.

The scientific community insists such work is necessary for vaccine development. But with no guarantee these lab-made viruses will ever yield usable vaccines, the risks may far outweigh the rewards.

As H5N1 outbreaks spread globally, the distinction between natural and lab-made strains becomes murkier. If a synthetic virus escapes containment, tracing its origins could prove impossible. Worse, governments and institutions continue these experiments with minimal oversight—and even less transparency.

Watch Jon Fleetwood and Maria Zeee discussing biomedical terrorism using the bird flu pathogen in this clip.

This video is from the Tanjerea channel on Brighteon.com.

More related stories:

Dr. Lee Merritt: SARS-CoV-2 is a genetically engineered BIOWEAPON.

Dr. Bryan Ardis: Engineered COVID virus contains DOZENS of synthetic animal venoms.

US developing lethal, new genetically engineered viruses, including MOUSEPOX and MONKEYPOX… will these be used to demand MORE JABS in the name of “public safety?”

Sources include:

ZeroHedge.com

Nature.com

JonFleetwood.substack.com

Brighteon.com

Read full article here